Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors.
Saved in:
| Title: | Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors. |
|---|---|
| Authors: | Chakravarti AR; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States., Groer CE; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Gong H; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Yudistyra V; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States., Forrest ML; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Berkland CJ; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States. |
| Source: | Molecular pharmaceutics [Mol Pharm] 2023 Apr 03; Vol. 20 (4), pp. 1975-1989. Date of Electronic Publication: 2023 Feb 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
